⌘K

Login Start Free

Home/Filings/4/0000943819-26-000002

4//SEC Filing

Sandercock Brett 4

Accession 0000943819-26-000002

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:27 PM ET

Size

4.5 KB

Accession

0000943819-26-000002

Insider Transaction Report

Form 4

Period: 2026-01-02

Sandercock Brett

Chief Financial Officer

Transactions

Sale
ResMed Common Stock
2026-01-02$241.75/sh−1,000$241,750→ 86,495 total

Footnotes (1)

[F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001346064

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 5:27 PM ET
Size: 4.5 KB

View on SEC.gov